Russians do not have enough money for medicines.
The decline in real incomes of the population was reflected in the sales of drugs in pharmacies.
In June 2019, they collapsed by 4.7% compared to the same month in 2018, to 386.6 million packs, according to the DSM Group report.
In monetary terms, the decline was 2.4% to 73.9 billion rubles.
The groups of anticancer drugs and immunomodulators showed a big drop (by 12.5%), sales of antimicrobial drugs decreased by 9%. Sales of drugs for the treatment of diseases of the respiratory system decreased by 6.9%, and in the latter group, the sales of drugs for the treatment of obstructive diseases of the respiratory tract fell the most (by 11.5%).
The general director of the Rigla chain, Alexander Filippov, suggests that there is a connection with the lack of growth in real incomes of the population against the background of the rise in prices for goods and services due to the increase in VAT since 2019. In these conditions, the consumer has to save and use the available stocks of drugs, he explains. It is compelling to buy more expensive drugs due to the fact that low-price drugs are washed out of the pharmacy range, adds Sergey Shulyak, CEO of DSM Group. It is unprofitable for pharmacies to sell a large number of cheap drugs, the expert says.
At the same time, in general, according to the results of the first half of the year, the commercial drug market contracted for the first time since at least 2016 – by 3.9% in physical terms, writes Kommersant. In monetary terms, sales for six months increased by 0.6%, to 489.7 billion rubles.
Living standards in Russia continue to fall for the sixth consecutive year. By the cumulative total for the first half of the year, the Russians became poorer by another 1.3%, in addition to the collapse of 8.3% in 2014-18. In June, on average, Russian citizens lived on 34,425 rubles a month – that is, 1147 rubles, or $ 18 a day.